Xiaotong Li

16.7k total citations
62 papers, 944 citations indexed

About

Xiaotong Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaotong Li has authored 62 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Xiaotong Li's work include Cancer Genomics and Diagnostics (13 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer-related molecular mechanisms research (6 papers). Xiaotong Li is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer-related molecular mechanisms research (6 papers). Xiaotong Li collaborates with scholars based in China, United States and Japan. Xiaotong Li's co-authors include Keiji Itoh, Jérôme Ezan, Sergei Y. Sokol, Michael W. Klymkowsky, Hiroki Hikasa, Lajos Pusztai, Christos Hatzis, Nobuyuki Udagawa, Yasuhiro Kobayashi and Naoyuki Takahashi and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Xiaotong Li

56 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaotong Li China 16 587 272 256 115 96 62 944
Stephanie M. Cohen United States 17 350 0.6× 206 0.8× 252 1.0× 120 1.0× 117 1.2× 35 813
Jiangxue Wu China 19 777 1.3× 429 1.6× 251 1.0× 73 0.6× 104 1.1× 34 1.1k
Lingbao Ai United States 20 808 1.4× 238 0.9× 227 0.9× 93 0.8× 100 1.0× 25 1.1k
Shaojie Jiang China 11 562 1.0× 196 0.7× 239 0.9× 76 0.7× 56 0.6× 16 840
Haidong Gao China 17 643 1.1× 246 0.9× 210 0.8× 90 0.8× 88 0.9× 46 923
Ye Jin Jang South Korea 13 617 1.1× 328 1.2× 205 0.8× 237 2.1× 95 1.0× 15 1.1k
Jian Chai China 7 687 1.2× 283 1.0× 315 1.2× 98 0.9× 84 0.9× 16 1.1k
Şerif Şentürk Türkiye 16 796 1.4× 246 0.9× 295 1.2× 122 1.1× 66 0.7× 38 1.2k

Countries citing papers authored by Xiaotong Li

Since Specialization
Citations

This map shows the geographic impact of Xiaotong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotong Li more than expected).

Fields of papers citing papers by Xiaotong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaotong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotong Li. The network helps show where Xiaotong Li may publish in the future.

Co-authorship network of co-authors of Xiaotong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaotong Li. A scholar is included among the top collaborators of Xiaotong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaotong Li. Xiaotong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hui, et al.. (2025). Drug delivery for platinum therapeutics. Journal of Controlled Release. 380. 503–523. 4 indexed citations
3.
Qin, Qiaozhen, Heyang Zhang, Xiaotong Li, et al.. (2024). Deubiquitinase Mysm1 regulates neural stem cell proliferation and differentiation by controlling Id4 expression. Cell Death and Disease. 15(2). 129–129. 5 indexed citations
5.
Luan, Xin, Xiaotong Li, Jinghan Guo, et al.. (2023). Serum apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC) is a novel stroke biomarker. Clinica Chimica Acta. 553. 117734–117734. 1 indexed citations
6.
Sun, Mengzi, Shoumeng Yan, Di Zhao, et al.. (2022). Identified lncRNAs functional modules and genes in prediabetes with hypertriglyceridemia by weighted gene co-expression network analysis. Nutrition & Metabolism. 19(1). 33–33. 1 indexed citations
7.
Powles, Ryan L., Vikram B. Wali, Xiaotong Li, et al.. (2020). Analysis of Pre- and Posttreatment Tissues from the SWOG S0800 Trial Reveals an Effect of Neoadjuvant Chemotherapy on the Breast Cancer Genome. Clinical Cancer Research. 26(8). 1977–1984. 9 indexed citations
8.
Marczyk, Michał, Gauri A. Patwardhan, Jun Zhao, et al.. (2020). Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells. Cancers. 12(9). 2551–2551. 15 indexed citations
9.
Iwase, Toshiaki, Lajos Pusztai, Kim Blenman, et al.. (2020). Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer.. Journal of Clinical Oncology. 38(15_suppl). 3117–3117. 1 indexed citations
10.
Ma, Huanhuan, Jia Zhang, Lin Zhou, et al.. (2020). c-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3. Cell Reports. 30(12). 4235–4249.e6. 51 indexed citations
11.
Kumar, Sushant, Jonathan Warrell, Patrick D. McGillivray, et al.. (2020). Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences. Cell. 180(5). 915–927.e16. 94 indexed citations
12.
Li, Xiaotong, Sarah Warren, Vasiliki Pelekanou, et al.. (2019). Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial. Journal for ImmunoTherapy of Cancer. 7(1). 88–88. 46 indexed citations
13.
Yang, Yun, Youxun Liu, Rui Guo, et al.. (2018). The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling. Scientific Reports. 8(1). 3398–3398. 14 indexed citations
14.
Shi, Weiwei, Charlotte K.Y. Ng, Raymond S. Lim, et al.. (2018). Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity. Cell Reports. 25(6). 1446–1457. 59 indexed citations
15.
Li, Xiaotong, et al.. (2017). Inhibitory effects of microRNA-133b on ultraviolet-induced apoptosis of lens epithelial cells and its mechanism. Zhonghua shiyan yanke zazhi. 35(11). 977–983. 1 indexed citations
16.
Zhang, Jie & Xiaotong Li. (2015). [Dentoalveolar compensation in skeletal Class III patients treated with orthognathic surgery].. PubMed. 50(11). 656–60. 2 indexed citations
17.
Cui, Liang, Xiaotong Li, & Ding Zhang. (2012). Effect of fluid flow-induced shear stress on osteoclast formation induced by osteocyte.. PubMed. 34(3). 207–11. 5 indexed citations
18.
19.
Bartnes, Kristian, Xiaotong Li, Jean Paul Briand, Paul Travers, & Kristian Hannestad. (2000). The P9 peptide sidechain specificity of I-Ad. Immunology Letters. 70(3). 199–202. 1 indexed citations
20.
Youssoufian, Hagop, Frank A.E. Kruyt, & Xiaotong Li. (1999). Protein Replacement by Receptor-Mediated Endocytosis Corrects the Sensitivity of Fanconi Anemia Group C Cells to Mitomycin C. Blood. 93(1). 363–369. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026